Recombinant MG53 Protein Modulates Therapeutic Cell Membrane Repair in Treatment of Muscular Dystrophy

Article Tools

• Email

  Thank you for your interest in spreading the word about Science Translational Medicine.

  NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

  Your Email

  Your Name

  Send To

  Enter multiple addresses on separate lines or separate them with commas.

  You are going to email the following Recombinant MG53 Protein Modulates Therapeutic Cell Membrane Repair in Treatment of Muscular Dystrophy

  Message Subject (Your Name) has forwarded a page to you from Science Translational Medicine

  Message Body (Your Name) thought you would like to see this page from the Science Translational Medicine web site.

  Your Personal Message

  CAPTCHA

  This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

  Send Message
• Download Powerpoint
• Print
• Alerts

  Please log in to add an alert for this article.

  Log In with your AAAS ID

  Sign In to Email Alerts with your Email Address

  Email

  Log in
• Citation tools

  Recombinant MG53 Protein Modulates Therapeutic Cell Membrane Repair in Treatment of Muscular Dystrophy

  By Noah Weisleder, Norio Takizawa, Peihui Lin, Xianhua Wang, Chunmei Cao, Yan Zhang, Tao Tan, Christopher Ferrante, Hua Zhu, Pin-Jung Chen, Rosalie Yan, Matthew Sterling, Xiaoli Zhao, Moonsun Hwang, Miyuki Takeshima, Chuanxi Cai, Heping Cheng, Hiroshi Takeshima, Rui-Ping Xiao, Jianjie Ma

  Science Translational Medicine20 Jun 2012 : 139ra85

  Recombinant human MG53 protein can increase membrane repair after injury in cells and can reduce pathology in animal models of muscle injury and muscular dystrophy.

  Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
• Share

  Recombinant MG53 Protein Modulates Therapeutic Cell Membrane Repair in Treatment of Muscular Dystrophy

  By Noah Weisleder, Norio Takizawa, Peihui Lin, Xianhua Wang, Chunmei Cao, Yan Zhang, Tao Tan, Christopher Ferrante, Hua Zhu, Pin-Jung Chen, Rosalie Yan, Matthew Sterling, Xiaoli Zhao, Moonsun Hwang, Miyuki Takeshima, Chuanxi Cai, Heping Cheng, Hiroshi Takeshima, Rui-Ping Xiao, Jianjie Ma

  Science Translational Medicine20 Jun 2012 : 139ra85

  Recombinant human MG53 protein can increase membrane repair after injury in cells and can reduce pathology in animal models of muscle injury and muscular dystrophy.

  Share This Article: Copy